Use this URL to cite or link to this record in EThOS:
Title: Effect of INPP4B loss on DNA repair and treatment strategies in ovarian cancer
Author: Ip, L. R. H.
ISNI:       0000 0004 8497 6181
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2016
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Treatment options for ovarian cancer patients remain limited and overall survival is less than 50 percent despite recent clinical advances. The lipid phosphatase inositol polyphosphate 4-phosphatase type II (INPP4B) has been described as a tumour suppressor in the PI3K/Akt pathway with loss of expression found most pronounced in breast, ovarian cancer and melanoma. Using microarray technology a DNA repair defect was identified in INPP4B-deficient MCF-10A cells. After validation of the microarray data, I further characterised the DNA repair defect by comet assays and quantification of γH2AX, RAD51 and 53BP1 foci formation through immunofluorescence studies. Mechanistically, with collaborative efforts I discovered that INPP4B forms a protein complex with the key players of DNA repair, ATR and BRCA1, in GST pulldown and 293T overexpression assays. Finally, I assessed whether or not INPP4B loss resulted in synthetically lethal interaction with PARP inhibition, as evidenced with tumours harbouring BRCA1/2 mutations. INPP4B loss resulted in significantly increased sensitivity towards PARP inhibition, in vitro and in vivo. Given that INPP4B loss has been found in 40% of ovarian cancer patients, this study provides the rationale for establishing INPP4B as a biomarker of PARP inhibitor response, and consequently offers novel therapeutic options for a significant subset of patients.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available